Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease
about
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infectionCXCL9 contributes to antimicrobial protection of the gut during citrobacter rodentium infection independent of chemokine-receptor signalingIs IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma?Bioinformatics analysis of key genes and latent pathway interactions based on the anaplastic thyroid carcinoma gene expression profileCytokines, Graves' disease, and thyroid-associated ophthalmopathyTherapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse.Alternative medicines as emerging therapies for inflammatory bowel diseases.Interaction of mature CD3+CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid.Discrimination between active and latent tuberculosis based on ratio of antigen-specific to mitogen-induced IP-10 productionRole for interferon-gamma inducible chemokines in endocrine autoimmunity: an expanding field.Tissue-specific regulation of CXCL9/10/11 chemokines in keratinocytes: Implications for oral inflammatory disease.CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia?Autoimmune thyroid disorders in hepatitis C virus infection: Effect of interferon therapyInterferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes.Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathyCXCR3, CCR5, and CRTH2 Chemokine Receptor Expression in Lymphocytes Infiltrating Thyroid Nodules with Coincident Hashimoto's Thyroiditis Obtained by Fine Needle Aspiration Biopsy.Novel Therapies for Thyroid Autoimmune Diseases.Expression of the interferon-inducible chemokine IP-10 (CXCL10), a chemokine with proposed anti-neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma.Increased serum levels of interferon-gamma-inducible protein 10 and monokine induced by gamma interferon in patients with haemophagocytic lymphohistiocytosis.Intersection of Chemokine and TSH Receptor Pathways in Human Fibrocytes: Emergence of CXCL-12/CXCR4 Cross Talk Potentially Relevant to Thyroid-Associated Ophthalmopathy.Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection.Higher levels of circulating CXCL-9 and CXCL-11 in euthyroid women with autoimmune thyroiditis and recurrent spontaneous abortions.The relationship between thyroid function, serum monokine induced by interferon gamma and soluble interleukin-2 receptor in thyroid autoimmune diseases.Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy.Association of the polymorphisms of chemokine genes (IL8, RANTES, MIG, IP10, MCP1 and IL16) with the pathogenesis of autoimmune thyroid diseases.Differential role of CXCR3 in inflammation and colorectal cancer.Aberrant MRP14 expression in thyroid follicular cells mediates chemokine secretion.Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients
P2860
Q24303828-389BF04E-A9BE-4E96-BCE0-56A0B61E23CAQ26830844-EFD6A1B3-B573-4170-B218-4514BB85EE5FQ27321362-871A55E4-AFC2-4733-A86C-9DFC11702892Q33391067-36A65013-4095-4A78-9651-D179CCCFA81EQ33579281-44E9950D-639D-46D9-BB97-30205E7DAA2BQ33889209-3B10EE74-ADC3-45F5-9500-D7EF76EC6E72Q33892454-48F26BE5-5878-4812-B222-32EF6A9F03D8Q34069427-13E735DE-C891-4C5F-8293-257D9DE69FD2Q34568588-8591D47D-A44A-441E-8B89-7A74FCF965E1Q34983098-F8DD19FB-B7C0-4775-B89E-894E6DA983E1Q35124570-7ACDD4AC-BAE0-44A5-B8C0-3E84DA7ED90DQ36295299-229B4718-68C6-4884-9F57-A34AECBA3FEEQ36676660-762369DB-6484-441E-A187-1E79FC22DE69Q36862264-148CE845-7CFC-4706-9C12-FCBBC5D6309DQ36960285-6573FACE-56AF-46E8-9E68-F1159CC4D4C1Q37017200-7472D273-D25F-4214-960B-EBFAC6CB166EQ37411605-8E2CB58F-FE95-4DDD-9FA1-3B86DC463F49Q38743624-ADE87EA9-C77E-43F4-BC46-5285DF920B94Q40449755-AA900C89-F3B2-49ED-A627-75E0C3D848B0Q40551833-49F34D6F-5C80-4DDE-92BA-6B7ED040B5B6Q41640757-F12A0CB7-4128-4A37-9E2F-97DE4C754711Q42498132-75211417-CCF8-4B04-8ADE-DB40F2D67B1DQ42981405-F3ABCFBC-0406-42B9-BF84-575AB7CEBC2AQ44926572-EEFA0474-FBA9-4D10-944B-2DEE1328729CQ46105484-D92807BC-66E5-4B27-B8DD-B23CCA2FE9BEQ46907006-726A4E1E-E0E8-456E-A8B4-15101CD5BBD7Q51728143-87B5D055-FA5B-4DEC-824A-24E8682CD116Q55131902-468F6D34-D3CF-44F9-8C46-08B0DC72510CQ55265526-E464EEEB-7C7C-4F69-8546-A0EE3A7C0E7EQ58816247-4E50605A-0550-4BFC-B52B-79A0E4E690FB
P2860
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@ast
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@en
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@nl
type
label
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@ast
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@en
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@nl
prefLabel
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@ast
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@en
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@nl
P2093
P2860
P50
P3181
P1476
Expression of IP-10/CXCL10 and ...... h recent-onset Graves' disease
@en
P2093
Andrea Buonamano
Antonio Bellastella
Mario Rotondi
Mario Serio
Massimo Tonacchera
Michela Francalanci
Paolo Vitti
Stefano Milani
P2860
P304
P3181
P356
10.1016/S0002-9440(10)64171-5
P407
P577
2002-07-01T00:00:00Z